News | October 21, 2011

First Male in Texas Treated With SAVI Breast Cancer Therapy

October 21, 2011 — When we think about breast cancer, most of us think of it as a disease only affecting women. The truth is, about 2,140 new cases of invasive breast cancer will be diagnosed among men this year, according to the American Cancer Society.

George Ross was one of those men. Ross is also the first man in Texas to receive the SAVI therapy, an advanced treatment device for breast cancer that provides multiple benefits for patients. The therapy reduces the course of treatment time from six weeks to just five days. Ross was treated at Methodist Dallas Medical Center.

The SAVI applicator can provide important advantages for patients with early-stage breast cancer by delivering a form of radiation therapy known as breast brachytherapy. This approach, which targets the tumor site from inside the breast, is becoming a more widely used alternative to traditional radiation.

Breast brachytherapy typically involves two treatments per day for only five days. This shorter timeframe makes it far more convenient than traditional, external-beam radiation. The latter is delivered five times a week and takes six or seven weeks.

In addition to shortening the therapy time, breast brachytherapy with SAVI minimizes radiation exposure for healthy tissue; this reduces impacts to critical structures such as the skin, heart, lungs and ribs.

"While male breast cancer is much less common than its female counterpart, we are pleased to offer the same leading edge technology for both men and women," says Arve Gillette, M.D., an independently practicing radiation oncologist on the medical staff at Methodist Health System. "We look forward to participating in other advances in treating this disease, whether for women, or the rare but increasingly frequent occurrences among men."

Ross, who discovered the lump that led to his diagnosis of breast cancer, is doing well after the treatment and offers a word of advice to other men. "Check yourself regularly," he says. "You never know."

Methodist Dallas Medical Center was named a Center of Excellence in accelerated partial breast irradiation (APBI) for its use of the SAVI applicator. The designation recognizes a facility's dedication to education, training and experience in APBI.

To qualify, physicians, medical physicists, and clinical staff are required to complete a comprehensive training and education program demonstrating proficiency in delivering radiation therapy with SAVI. Recognized facilities have also expressed a commitment to patient education, advocacy and awareness of advanced breast cancer treatments.

For more information: www.methodisthealthsystem.org

Related Content

Varian Showcases Advanced Cancer Care Solutions at AAPM 2018
News | Radiation Therapy | July 27, 2018
Varian announced it will be showcasing its advanced cancer care solutions, including a new version of the Eclipse...
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Intraoperative Radiotherapy Provides Lifetime Cost Savings, Health Benefits for Early-Stage Breast Cancer Treatment
News | Brachytherapy Systems, Women's Healthcare | December 19, 2017
iCAD Inc. announced the results of a landmark study that showed the benefits of adjunct intraoperative radiation...
Cleveland Clinic Leads Development of New Guidelines for Radiation in Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 31, 2017
October 31, 2017 — Cleveland Clinic researcher Chirag Shah, M.D., recently led the development of updated guidelines
Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
Overlay Init